Active Substance: Insulin-Like Growth Factor 1,DES
Concentration: 1mg
Pack Size: vial
Manufacturer: Deus Medical
Brand Name:
SKU: P368
Shipping From
IGF-1 DES (Insulin-Like Growth Factor 1, DES) is a modified form of IGF-1 that is known for its potent anabolic effects on muscle growth and repair. It plays a critical role in the growth and development of muscle tissue, making it a popular choice among athletes and bodybuilders.
Product Overview
IGF-1 DES has a higher binding affinity for IGF receptors, which enhances its potency and effectiveness in stimulating muscle growth and recovery. This peptide is particularly beneficial for those looking to maximize their performance and achieve faster recovery from intense training.
Usage and Dosage
The typical dosage for IGF-1 DES ranges from 50 to 100 mcg per injection, administered subcutaneously. Users often take it once daily, ideally around workouts or meals to enhance its anabolic effects. Consulting with a healthcare provider is crucial to tailor the dosage effectively based on individual needs.
Side Effects & Management
IGF-1 DES is generally well-tolerated, but potential side effects may include hypoglycemia, injection site reactions, and joint pain. It is essential for users to monitor their health and consult a healthcare provider if they experience significant discomfort or unusual symptoms.
Patient Safety Information
This product is intended for healthy individuals seeking to enhance muscle growth and recovery. It should be used under medical supervision, particularly for those with existing health conditions or those taking other medications.
FAQs
What benefits can I expect from using IGF-1 DES?
Users can expect significant increases in muscle mass, improved recovery times, and enhanced overall physical performance.
How is IGF-1 DES administered?
It is typically administered via subcutaneous injection for optimal absorption and effectiveness.
Is IGF-1 DES safe for long-term use?
Current research suggests that it is safe for short-term use, but long-term effects should be discussed with a healthcare provider.